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donors are eliminated from consideration to avoid early
graft failure.2 Once accepted for transplantation, organs
with occult injury have the potential to result in the
death of the recipient. The typical delay in onset of this
contractile dysfunction suggested to us that the altered
expression of select myocardial genes might play a role.
If so, then defining the molecular changes induced by
brain death would be an important first step in the res-
cue or protection of these hearts.
C entral nervous system disturbances are well recog-nized to produce myocardial dysfunction and injury.
Brain death from increased intracranial pressure
(increased ICP) produces echocardiographic alter-
ations, hemodynamic instability, myocardial isoenzyme
release, and histologic injury. It also causes massive
neuronal depolarization and excessive catecholamine
release.1 The myocardial dysfunction accompanying
brain death can be so severe that an estimated 20% of
Objectives: The depressed myocardial function observed in brain dead
organ donors has been attributed to massive sympathetic discharge and
catecholamine cardiotoxicity. Because elevated catecholamines are asso-
ciated with altered myocardial gene expression, we investigated whether
acute brain death from increased intracranial pressure alters the
expression of myocardial gene products important in contractility.
Methods: A balloon expansion model was used to increase intracranial
pressure in rabbits (n = 22). At timed intervals after brain death, mean
arterial pressure, heart rate, electrocardiograms, histologic myocardial
injury, and systemic catecholamines were assessed. Messenger RNA lev-
els encoding myofilaments, adrenergic receptors, sarcoplasmic reticu-
lum proteins, transcription factors, and stress-induced programs were
measured with blot hybridization of total left ventricular RNA. Results:
Increased intracranial pressure induced an immediate pressor response
that temporally coincided with diffuse electrocardiographic ST segment
changes. Systemic epinephrine and norepinephrine levels concurrently
increased (5- to 8-fold within 1 minute), then fell below baseline within
2 hours, and remained depressed at 4 hours. By 1 hour, histologic injury
was evident. Four hours after the induction of increased intracranial
pressure, levels of messenger RNA–encoding skeletal and cardiac a -
actins, egr-1, and heat shock protein 70 were significantly increased.
Sham-operated animals did not exhibit these changes. Conclusions: Select
changes in myocardial gene expression occur in response to increased
intracranial pressure and implicate ventricular remodeling in the
myocardial dysfunction associated with acute brain death. (J Thorac
Cardiovasc Surg 1999;117:365-74)
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A newly emerging concept is that hypertrophy, a com-
pensatory response of the heart to injury underlies car-
diac pathologic conditions3 and may play a role in
altered function. Hypertrophy results not only in a quan-
titative increase in myocyte size but also in qualitatively
different patterns of gene expression and is known to
alter performance without changing morphology.4
Because catecholamines induce hypertrophy in cell cul-
ture5,6 and are elevated in brain death,2,7,8 perhaps brain
death initiates a hypertrophic response in vivo, which
adversely affects cardiac function.
We tested the hypothesis that acute brain death from
increased ICP alters the expression of left ventricular
(LV) myocardial genes important in contractility. The
physiologic, electrocardiographic, and histologic param-
eters were assessed at timed intervals with a balloon
expansion model of increased ICP in rabbits. Because
sympathetic stimulation of cardiomyocytes affects sev-
eral subcellular compartments and to more fully char-
acterize the response of the myocardium, expression
levels of mRNAs encoding cardiac myofilaments,
adrenergic receptors, sarcoplasmic reticulum proteins,
and heat shock protein 70 (hsp70) were measured.
Additionally, immediate early genes known to be regu-
lated by adrenergic receptor activation were assayed as
early markers of transcriptional change.
Methods
Surgical models and experimental design. All experi-
mental animals received humane care in compliance with
“Principles of Laboratory Animal Care” (National Society for
Medical Research) and the “Guide for Care and Use of
Laboratory Animals” (National Institutes of Health Publi-
cation No. 86-23, revised 1985). New Zealand White rabbits
(3.5-4.0 kg) were anesthetized with a regimen designed
specifically to allow sympathetic activity (fentanyl [0.1
mg/kg intramuscularly] followed by inhaled isoflurane [3%
on induction, 1.5% after induction]).
Mechanical ventilation through a tracheostomy was normal-
ized with serial arterial blood gas measurements. Pulse and
blood pressure were continually monitored through a carotid
arterial line and recorded at baseline and periodically until
death. Invasive intrathoracic monitoring was avoided by design
to minimize catecholamine release as a result of surgical stress.
Electrocardiographic recordings (limb leads) were taken at
baseline and periodically after brain injury. Except for histo-
logic features, all data were generated from the same animals.
Animals were randomly assigned to 1 of 3 groups: untreated
naive rabbits (n = 4), experimental increased-ICP rabbits (n =
9), and sham-operated rabbits (n = 9). Untreated, naive rabbits
were anesthetized and rapidly killed to establish baseline
mRNA expression levels (time = 0). Experimental (increased-
ICP) animals had a 5-mm burr hole placed in the right parietal
calvarium, and an 8F balloon-tipped catheter was inserted
between the dura and calvarium. At time point 0, the balloon
was rapidly inflated with 3 mL saline solution to produce
increased ICP. Brain death occurred within minutes of balloon
inflation, as assessed by episodic electroencephalograms.
Sham-operated rabbits also underwent burr hole placement,
but no intracranial catheter was inserted to avoid any increased
ICP. Animals in both experimental and control groups were
killed at 1, 2, and 4 hours (n = 3 per time point for a total; n =
9 per experimental group). Hearts were rapidly excised, rinsed
with cold heparinized saline solution, and the right and left
ventricles were dissected. Myocardial tissue was snap frozen in
liquid nitrogen and stored at –70°C for mRNA analysis.
mRNA analysis. Total RNA was isolated with the guani-
dinium isothiocyanate/CsCl method.9 LV tissue (0.5 g) was
pulverized under liquid nitrogen, homogenized in 4 mol/L
guanidinium isothiocyanate/CsCl (9 mL) using a tissue
homogenizer (maximum speed, 1 minute; PT10-3; Polytron,
Brinkman Instruments, Westbury, NY), and adjusted to 2
mol/L cesium chloride (1 g/2.5 mL). The homogenate was
layered onto a 5.7 mol/L cesium chloride cushion and cen-
trifuged at 210,000g for 16 to 20 hours at 20°C. The RNA
pellet was resuspended in water and stored at –70°C.
The integrity of mRNA and appropriate hybridization and
wash stringencies were confirmed by Northern blot. Slot blot
hybridization was used for quantitative analyses.10 Four micro-
grams of total RNA from each specimen were immobilized on
nitrocellulose membrane. Membranes were prehybridized at
42°C overnight in hybridization buffer (4 · SSC, 50 mmol/L
NaH2PO4, 0.2% sodium dodecylsulfate, 5 · Denhardt’s solu-
tion, 200 mg/mL transfer RNA, 50% formamide) and then
sequentially hybridized with a series of specific complemen-
tary [32P]-labeled probes. Between probings, membranes were
stripped at 80°C for 2 minutes in 1% glycerol and exposed to
film overnight to verify the absence of signal.
Oligonucleotide probes were radiolabelled with [32P]-
adenosine triphosphate (ATP) and the T4 polynucleotide
kinase reaction. Complementary DNAs were radiolabelled
with [32P]-deoxycytidine triphosphate and a random primed
Klenow reaction. Specific gene probes and hybridization
conditions tested are summarized in Table I. Total poly(A)+
RNA was estimated by hybridization with a [32P]-poly d(T)
probe (Clontech Labs Inc, Palo Alto, Calif).
Densitometry and data standardization. Quantitation of
the hybridization signal was performed by densitometric
scanning of autoradiograms exposed within the linear range
of the radiograph film with a laser densitometer (Ultrascan
XL; Pharmacia LKB, Piscataway, NJ). The integrals for each
specimen were calculated with the GELScan 1D analysis
program (Pharmacia LKB). To adjust for variations in load-
ing, the optical density was divided by the amount of total
poly(A)+ RNA in each specimen. The mean of this ratio was
then normalized to the mean value of naive hearts (time = 0)
such that all subsequent time points are given relative to naive
levels. Data are reported as mean ± SEM.
Quantitation of systemic catecholamines. Plasma epi-
nephrine and norepinephrine were measured before and at 0,
1, 5, 10, 15, 30, 45, and 60 minutes after induction of in-
The Journal of Thoracic and
Cardiovascular Surgery
Volume 117, Number 2
Yeh et al   367
creased ICP and every 60 minutes thereafter. Levels were
determined by electrochemical detection with an electro-
chemical detector (Coulochem II; ESA, Inc, Bedford,
Mass).* Catecholamines were extracted from plasma with
alumina oxide and separated by high-pressure liquid chro-
matography with an isocratic mobile phase comprised of
85% NaH2PO4 and 15% acetonitrile adjusted to pH 3.0 with
H3PO4 . Run time was approximately 28 minutes. The appa-
ratus was standardized daily at the 50, 200, and 700 pg/mL
concentration level with a mean coefficient of variation (n =
5) of 6.4% and 4.4% for epinephrine and norepinephrine,
respectively. The limit of detection was 10 pg/mL.
Histologic evaluation. To evaluate histologic injury, a sep-
arate group of hearts (n = 4) were harvested. One hour after
increased ICP (or sham operation) and systemic hepariniza-
tion (1000 units, intravenously), excised hearts were
immersed in saline solution (4°C) and sequentially perfused:
(1) with saline solution until residual blood was removed, (2)
for 2 minutes with modified Karnovsky’s fixative (1% glu-
taraldehyde, 1.5% paraformaldehyde in 0.1 mol/L sodium-
cacodylate buffer, pH 7.2), and (3) for 3 minutes with 3% glu-
taraldehyde and 1.5% paraformaldehyde in the same buffer.
Two-millimeter transverse sections were immersed in fixative
(3% glutaraldehyde and 1.5% paraformaldehyde) for 1 hour
at 21°C, then overnight at 4°C. Each specimen was dehydrat-
ed and embedded in paraffin blocks. Three nonadjacent 7-m m
sections (taken from separate blocks) were stained with
hematoxylin and eosin.
These sections were evaluated by a cardiac pathologist
blinded to experimental group. A glass template was used to
identify 8 regions per section. Each region was semiquantita-
tively evaluated for 4 characteristics: the presence of contrac-
tion bands, myocytolysis, pyknotic nuclei, and loss of
myofibrillar striations. Respectively, scores of 0, 0.5, 1.0, 1.5,
and 2.0 indicated that 0%, 1% to 25%, 26% to 50%, 51% to
75%, and 76% to 100% of cells within that section manifested
the indicated characteristic.
Statistical analyses. Statistical analyses were performed
with SAS (Statistical Analysis Systems, Cary, NC). Hemo-
dynamic and catecholamine data (both of which were repeated
measures over time) were analyzed between groups by rank-
ordered 2-way analysis of variance (ANOVA) and over time by
rank-ordered 1-way ANOVA. Results were rank ordered
because variances within groups were dissimilar (PROC
MIXED; SAS). Histologic results were analyzed by ANOVA
comparing 2 groups and modeling for the variation of multiple
samplings from each animal (PROC GLM; SAS). mRNA
results were analyzed with 2-way ANOVA, treating each time
point as an independent group because different animals were
killed to generate each time point (PROC GLM; SAS). A trend
toward statistical significance was accepted at P ≤ .10.
Results
Hemodynamic and echocardiographic monitor-
ing. Simple hemodynamic parameters were measured.
Immediately after balloon inflation, the pressor com-
ponent of a Cushing response11 (bradycardia and
hypertension, associated with increased ICP) occurred
in all increased-ICP animals. Bradycardia was incon-
Table I. Conditions of probing
PROBE plasmid Base pairs (RE fragment) Hybridization conditions* Wash stringency
Oligo dT oligonucleotide 29 nt (none) (2) 2.0· SSC, 0.1% SDS 21°C, 3· 5´
Cardiac a -actin pHP34.LK300 171 bp (EcoR I) (3) 0.5· SSC, 0.1% SDS 50°C, 3· 10´
Skeletal a -actin pHP34.LK295 136 bp (Fnu4H1) (3) 0.5· SSC, 0.1% SDS 50°C, 3· 10´
a -MHC pMHCa 81.a -MHC 1500 bp (PstI) (1) 1.0· SSC, 0.1% SDS 37°C, 3· 10´ 
b -MHC p251-1.b -MHC 300 bp (Pst I) (1) 1.0· SSC, 0.1% SDS 37°C, 3· 10´
a 1-AR pTZ18R.A1-AR 850 bp (BamH I) (1) 1.0· SSC, 0.1% SDS 37°C, 3· 10´
b 1-AR pSP65.b 1-AR 1300 bp (Pst I-Sma I) (1) 1.0· SSC, 0.1% SDS 37°C, 3· 10´
CaATPase pUC18.SERCA 2a 220 bp (BamH I and Hind III) (1) 2.0· SSC, 0.1% SDS 37°C, 3· 10´
P1b pGEM3z.plb7 600 bp (BamH I-EcoR I) (1) 2.0· SSC, 0.1% SDS 37°C, 3· 10´
RyR pBluSk+.CRR 1500 bp (EcoR I-Nco I) (1) 0.5· SSC, 0.1% SDS 50°C, 3· 10´
c-fos pSP65.cfos 2137 bp (EcoR I) (1) 2.0· SSC, 0.1% SDS 37°C, 3· 10´
c-jun oligonucleotide 40 nt (none) (2) 0.5· SSC, 0.1% SDS 40°C, 3· 10´
Egr-1 pUC13 191.egr1 3100 bp (EcoR I) (1) 1.0· SSC, 0.1% SDS 50°C, 3· 10´
Hsp70 pH2.3 hsp70 2300 bp (BamH I-Hind III) (4) 2.0· SSC, 0.1% SDS 37°C, 3· 10´
bp, base pair; nt, Nucleotide.
*(1) = 42°C overnight in hybridization buffer: 4 · †SSC, 50 mmol/L NaH2PO4, 0.2% SDS, ‡5 · Denhardt’s solution, 200 mg/mL tRNA, 50% formamide.
(2) = 42°C overnight in hybridization buffer: 4.8 · §SSPE 15% formamide, 5 · Denhardt’s solution, 200 mg/mL tRNA, 2.5% SDS.
(3) = 35°C overnight in hybridization buffer: 4 · SSC, 50 mmol/L NaH2PO4, 5 · Denhardt’s solution, 50% formamide, 200 mg/mL tRNA.
(4) = 42°C overnight in hybridization buffer: 4 · SSC, 50 mmol/L NaH2PO4, 0.2% SDS, 5 · Denhardt’s solution, 200 mg/mL tRNA, 50% formamide.
†SSC (saline, sodium citrate solution): 60 mmol/L NaCl, 6 mmol/L Na3 citrate, pH 7.0 (final concentration).
‡50 · Denhardt’s solution: 5 g Ficoll, 5 g bovine serum albumin, 5 g polyvinyl pyrrolidine, RNA water to 500 mL.
§SSPE (saline, sodium phosphate, EDTA solution): 150 mmol/L NaCl, 10 mmol/L NaH2PO4H20, 1 mmol/L EDTA, pH 7.4.
*Farthing D, Sica DA, Gehr WBT, Fakhry I. A novel analytical
method for determination of plasma catecholamines. Personal
communication.
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sistently observed in the increased-ICP group, lasting
only a few beats. Tachycardia was invariably present
(Fig l, A). At 1 minute, the heart rate of increased-ICP
animals increased from a mean of 240 beats/min to 295
beats/min. By 5 minutes, heart rate fell to 247
beats/min and gradually declined to 190 beats/min over
4 hours, a level significantly lower than baseline.
Hypertension was invariably present (Fig l, B). Mean
arterial blood pressure increased significantly from a
baseline value of 73 mm Hg (systolic/diastolic, 93/64
mm Hg) to a peak of 96 mm Hg (systolic/diastolic,
118/87 mm Hg) by 1 minute. By 5 minutes, mean arte-
rial pressure dropped to 52 mm Hg (systolic/diastolic,
68/34 mm Hg) and by 4 hours to 26 mm Hg (sys-
tolic/diastolic, 42/20 mm Hg), significantly below
baseline levels. Sham-operated animals showed no sig-
Fig 1. The effect of increased ICP on heart rate and mean
arterial pressure. The temporal profile of heart rate (A) and
mean arterial pressure (B) are depicted for sham-operated
(dashed lines) and increased ICP–injured animals (solid
lines). Data are reported as mean ± SEM. Differences
between groups are significant (P < .05) in A and B at all time
points except as follows: A, 0.00, 0.17, 0.25, 2.50, 2.75, and
3.75 hours; B, 0.00 hours. Significant changes over time
within experimental groups were also analyzed. Within the
increased ICP–injured group, changes over time are signifi-
cantly different than baseline (time point 0) at all time points
except as follows: A, 0.08, 0.17 hours; B, none. Within the
sham-operated group, changes over time were not signifi-
cantly different from baseline (time point 0) except as fol-
lows: A, none; B, 0.75, 1.00, 1.25, 1.50, 1.75, 2.00, 2.50, and
2.75 hours.
A
B
Fig 2. The effect of increased ICP on systemic epinephrine
and norepinephrine levels. The temporal profiles of systemic
catecholamine levels are plotted in sham-operated (dashed
line) and increased ICP–injured (solid line) animals. A,
Systemic levels of epinephrine. B, Systemic levels of norepi-
nephrine. The limit of detection is 10 pg/mL. Data are given
as mean ± SEM. Differences between groups are significant
(P < .05) in A and B at all time points except as follows: A,
0.00 and 0.08 hours; B, 0.00 and 0.08 hours. Significant
changes over time within experimental groups were also ana-
lyzed. Within the increased ICP–injured group, changes over
time that are significantly different from baseline (time point
0) are as follows: A (epinephrine levels), significantly differ-
ent at all time points; B (norepinephrine levels), significantly
different at all time points except 0.08 hours. Within the
sham-operated group, there were no significant changes over
time in epinephrine or norepinephrine levels.
B
A
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nificant change in heart rate over 4 hours and manifested
significantly higher mean arterial pressure when com-
pared with the increased-ICP group.
Electrocardiographic ST segments were also evaluat-
ed. Abnormal ST segments were observed in all rabbits
in the increased-ICP group, with no change in sham-
operated animals over time. Electrocardiograms
showed sustained ST segment depression, ST segment
elevation, or T-wave inversion, which persisted vari-
ably over the course of the experiment.
Systemic catecholamine levels. The pattern of
response of systemic catecholamine levels was uniform
in all increased-ICP animals, with a massive spike in
systemic levels of both epinephrine and norepinephrine
1 minute after balloon inflation. Systemic epinephrine
levels (Fig 2, A) started at a baseline level of 146
pg/mL, were significantly elevated 5-fold (722 pg/mL)
at 1 minute, dropped below baseline (33 pg/mL) by 5
minutes, and were significantly decreased to unde-
tectable levels (<10 pg/mL) by 2 hours. Systemic nor-
epinephrine (Fig 2, B) behaved similarly, starting at a
baseline level of 387 pg/mL, increasing 7- to 8-fold (P
< .05) by 1 minute (3042 pg/mL), dropping below
baseline at 5 minutes (286 pg/mL), and decreasing sig-
nificantly to 25% of baseline levels by 1 hour (81
pg/mL). The decrease in catecholamine levels preced-
ed the decline in heart rate but was concurrent with the
decline in mean arterial pressure. No significant
changes in systemic levels of epinephrine or norepi-
nephrine were found in sham-operated animals.
Histologic evidence of injury. A separate group of
hearts were examined for histologic injury 60 minutes
after increased-ICP or sham operation. Representative
examples of increased-ICP and sham-operated animals
are shown in Fig 3, A and B. Objective grading of his-
tologic injury is summarized in Table II. Increased-ICP
hearts exhibited significantly more cytoplasmic clear-
ing and loss of myofibrillar striations, indicative of
Fig 3. The effect of increased ICP on LV myocardial histologic features. Representative light micrographs of LV
are shown 60 minutes after burr hole placement in sham-operated controls (A) and after induction of increased
ICP (B). Increased ICP resulted in pronounced contraction band necrosis (arrows) and myocytolysis (arrow-
head). In contrast, sham-operated controls manifested sparse lesions and minimal contraction banding.
(Hematoxylin and eosin stain; original magnification, · 300.)
Table II. Quantitative scoring of LV histologic injury
Histologic parameter Sham › ICP P value
Chromatin clumping 0.000 ± 0.000 0.108 ± 0.054 .01
Contraction banding 0.070 ± 0.027 0.354 ± 0.067 .0001
Cytoplasmic clearing 0.837 ± 0.062 1.369 ± 0.060 .0001
Loss of striations 1.131 ± 0.068 1.582 ± 0.055 .0001
› ICP, Increased ICP. Specimens were graded on a scale ranging from 0 (no injury) to 2 (diffuse injury). Three sections from each animal were divided into 8 regions,
resulting in 24 samplings from each animal. Data reported as mean ± SEM. All differences were statistically significant, and P values are summarized.
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myocardial injury. They also exhibited significantly
more contraction band necrosis, a pattern characteristic
of catecholamine toxicity. No interstitial mononuclear
cell infiltration and minimal pyknotic nuclei were seen.
Levels of mRNA
Levels of mRNAs encoding myofilament proteins.
Statistically significant increases in mRNAs for cardiac
and skeletal a -actin were found 4 hours after increased
Fig 4. Temporal profile of specific mRNA expression levels in response to increased ICP. A through M show lev-
els of specific mRNAs as a ratio to poly(A)+RNA in that same specimen. These ratios are then normalized to the
mean value of naive ventricle (time = 0). Data are reported as mean ± SEM. Time point 0 depicts steady state
mRNA levels of naive hearts. The SEM of this group is extended horizontally across the graph as a baseline ref-
erence (shaded bar). The asterisk (*) denotes a statistically significant difference between groups at a given time
(P < .05 by ANOVA). ø denotes a trend toward significance (P < .1). Sham-operated controls are indicated by the
solid line. Increased-ICP animals are indicated by the dashed line. 
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ICP (Fig 4, A and B) compared with sham-operated
animals. In contrast, no differences in b –myosin heavy
chain (MHC) mRNA expression levels were found
between increased-ICP and sham-operated hearts (Fig
4, D). Levels of messages encoding a -MHC signifi-
cantly increased in both increased-ICP and sham-oper-
ated hearts by 4 hours (Fig 4, D); however, no signifi-
cant differences were detected between groups.
Levels of mRNAs encoding adrenergic receptors.
Analysis of these message levels relative to sham-oper-
ated controls showed no effect of increased ICP on
either a 1-adrenergic receptor or b 1-adrenergic receptor
mRNA levels (Fig 4, E and F).
Levels of mRNAs encoding sarcoplasmic reticu-
lum proteins. Blots were sequentially hybridized to
CaATPase, phospholamban, and ryanodine receptor
Fig 4 Cont’d. For legend see Fig 4.
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cDNA probes (Fig 4, G, H, and I, respectively). When
mRNAs in increased-ICP hearts were compared with
sham-operated hearts, a trend towards a significant
increase (P = .076) in CaATPase mRNA level was found
4 hours after increased ICP (Fig 4, G). The relative lev-
els of mRNAs encoding the calcium-release channel
(ryanodine receptor) and phospholamban were not sig-
nificantly different between groups (Fig 4, H and I).
Levels of mRNAs encoding immediate early genes
and cellular stress response genes. The expression lev-
els of immediate early genes, c-fos, c-jun, and egr-1,
were assayed (Fig 4, J, K, and L, respectively).
Increased ICP specifically increased levels of mRNA
encoding the transcription factor egr-1 relative to sham-
operated controls at 1 and 4 hours. A trend toward high-
er expression levels of c-fos mRNA was present in
increased-ICP hearts compared with sham-operated
controls. No significant differences in c-jun mRNA lev-
els were found between increased-ICP and sham-oper-
ated controls. A significant increase in hsp70 mRNA
was found 4 hours after increased-ICP hearts relative to
sham-operated controls (Fig 4, M).
Discussion
This study is the first evaluation of the molecular
consequences of brain death on the heart. A well-estab-
lished model was used to investigate whether brain
death alters myocardial gene expression in vivo. We
found an early pressor response (followed by hypoten-
sion), echocardiographic ST segment changes, an early
(1-minute) spike in systemic catecholamines, and his-
tologic injury. Select changes in mRNA levels encod-
ing egr-1, cardiac and skeletal a -actins, and hsp70 were
also noted (Table III). Increased ICP elicits a molecular
response similar to a 1-adrenergic receptor stimulation.
The complexity of in vivo systems makes it difficult
to determine whether catecholamines are directly
responsible for the observed changes in myocardial
gene expression. Other potential explanations are that
altered gene expression is a result of changing hemo-
dynamic loads or coronary vasospasm (and ischemia-
reperfusion injury). The molecular response of the
myocardium typically reflects its initiating stimulus.7
Whereas increased mechanical load and a -adrenergic
receptor stimulation lead to hypertrophy, ischemia
reperfusion injury does not. 
The phenotype of hypertrophy, whether initiated by
increased hemodynamic load or adrenergic receptor
activation, is characterized by selective changes in gene
expression (Table III).12 mRNAs for c-fos and c-
myc13,14 increase concurrently with increased expres-
sion of hsp70.15 Transient increases in a -actin mRNAs
and lasting increases in b -MHC mRNAs are also
found.12,16 Hypertrophy as the result of a -adrenergic
receptor activation can be further distinguished from
that induced by mechanical load by the induction of
egr-1.13,14 In our study, the increase in egr-1 implicates
catecholamines in the observed changes in gene
expression; however, the prolonged peak in egr-1
mRNA levels differs from that associated with a -
adrenergic receptor activation alone. The significance
of this finding is currently under investigation.
b -Adrenergic receptors can be regulated by (1)
receptor sequestration, (2) decreased levels of mRNAs
encoding the receptor, and (3) receptor uncoupling
from its second messenger. In previous studies of brain
Table III. Effect of › ICP contrasted to a -adrenergic receptor activation and congestive heart failure
Panel LV a 1 LV congestive 
mRNA group Specific mRNA (from Fig 4) LV › ICP stimulation heart failure
Myofilaments
Myosin heavy chains (MHC) a MHC A ~ › 5 ~
b MHC B ~ › 5,6 fl 23
a - Actins Cardiac a -actin C › › 5,6 fl 23
Skeletal a -actin D › › 5,6 ~
Adrenergic receptors (AR) a 1 AR E ~ NA NA
b 1 AR F ~ NA fl 26
Sarcoplasmic reticulum proteins CaATPase G ~ NA fl 23
Phospholamban H ~ NA fl 23
RyR I ~ NA fl 23
Immediate early genes c-fos J ~ › 1,6 NA
c-jun K ~ › 1,6 NA
Egr-1 L › › 1,6 NA
Heat shock protein 70 Hsp70 M › › 1,4 NA
Specific mRNAs evaluated are indicated. The direction of change in gene expression is depicted in LV › ICP. These are compared and contrasted with the clinical
scenario of congestive heart failure and the research scenario of specific a 1-adrenergic receptor stimulation. › denotes increased (P < .05); fl denotes decreased (P <
.05); ~ denotes no significant change; NA indicates that no data are available.
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death from increased ICP in rabbits, Bittner and col-
leagues8 documented uncoupling of the b -adrenergic
receptor from its adenylate cyclase second messenger
pathway (with no change in the number of cell surface
receptors). In our study, mRNA levels of b -adrenergic
receptor did not change in response to increased ICP.
Thus the prolonged egr-1 activation observed by us and
the uncoupling of b -adrenergic receptor demonstrated
by others suggests an imbalance in a - and b -adrenergic
receptor stimulation. Whether this contributes to the
myocardial dysfunction observed in hearts after brain
death is not known.
The role of ischemia reperfusion in this phenomenon
cannot be discerned histologically because ischemia-
reperfusion injury and catecholamines both have been
reported to cause contraction band necrosis. At the
molecular level, ischemia-reperfusion injury has been
reported to increase the expression of c-fos, hsp70,17,18
and sarcoplasmic reticulum proteins (CaATPase and
phopholamban).19,20 In this study, the increase in hsp70
mRNA levels is modest and late. This, in conjunction
with the rapid dissipation of elevated catecholamines
and the pressor response, argues that the contribution
of ischemia reperfusion is small.
The phenotype of congestive heart failure, a scenario
also associated with elevated catecholamines, bears
note because it differs from that observed in brain
death. Unlike brain death, congestive heart failure is
associated with chronic elevation of systemic cate-
cholamines21 and depressed levels of mRNAs encod-
ing proteins of the sarcoplasmic reticulum, a -actin and
b -MHC.22 Increased ICP results in the transient eleva-
tion of systemic catecholamines followed by rapid dis-
sipation to subnormal levels, and no significant
changes in mRNAs encoding sarcoplasmic reticulum
proteins are found (Table III). We suspect that these
differences reflect the levels and temporal course of
circulating catecholamines.
Conclusion
This study delineates the temporal profile of changes
in myocardial gene expression in response to increased
ICP. Collectively, the changes in gene expression impli-
cate, in particular, a -adrenergic receptor activation.14
Although the functional significance of these molecular
changes is unknown, defining these changes may pro-
vide important clues to ameliorate the functional deteri-
oration of myocardial function after brain death.
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Discussion
Dr Eric A. Rose (New York, NY). Is there any indication as
to how to modify this response?
Dr Yeh. We are currently in the process of analyzing brain
death in the presence of adrenergic blockade. Although it will
obviously be impossible to use adrenergic blockade in clini-
cal donors before head injury, I believe these data may have
broader implications in the realm of surgical stress.
Controlling catecholamine release during general anesthesia,
operation, weaning from cardiopulmonary bypass, and emer-
gence from anesthesia may prove to be very important. 
Dr Verdi J. DiSesa (Chicago, Ill). If I understood you cor-
rectly, you are measuring mRNA transcription, not gene
expression, in terms of protein levels. Is that correct? 
Dr Yeh. That is correct. 
Dr DiSesa. Because you are measuring mRNA and not
protein, as you know, protein levels are a balance between
synthesis and degradation. Maybe what you are really seeing
is a compensatory mechanism for some change in the subse-
quent protein metabolism of these brain-injured animals. 
Dr Yeh. We have not planned on pursuing that at the
moment. We are currently investigating the effects of adren-
ergic blockade, but I think it will be important to confirm that
changes in mRNA levels are ultimately reflected in altered
protein levels.
Mr Magdi Yacoub (London, England). In choosing the
mechanism, the neurohumoral factors that are implicated in
this, you concentrated on sympathetic a -agonists, but there
could be other neural or, indeed, humoral peptidergic or
other. Have you looked at any of these?
Dr Yeh. I think you are absolutely right to question this.
Although we have not investigated other neurohumoral fac-
tors, brain injury profoundly alters the hormonal milieu of the
body. I believe that one of the prime candidates may be thy-
roid hormone (which we plan on investigating).
Mr Yacoub. My second question is again about the target
genes. You have looked at a variety of contractile proteins, for
example, in phospholamban and calcium-handling proteins,
but what about other more fundamental things like G pro-
teins? Virginia Owens in our group has been looking at G
protein expression and found significant changes associated
with brain death. Have you looked at that? 
Dr Yeh. No, we did not examine G proteins.
Dr Michael Grosso (Moorestown, NJ). After the first 30
minutes, it appeared that the blood pressure was significantly
depressed and remained so for the remaining period of the
experiment. How much do you think hypoperfusion of the
myocardium contributed to your findings? Also, if you had
taken a little bit different approach and corrected that
hypotension, as we do in the clinical setting of donor treat-
ment, would that have altered your findings?
Dr Yeh. That is an excellent question. The in vivo model
mandated by our hypothesis makes it difficult to discern a
mechanism. I think there are 3 possible explanations.
Ischemia-reperfusion injury is one of those, although the lim-
ited induction of heat shock protein argues against this.
Altered myocardial loading from the observed alterations in
blood pressure is another. Finally, catecholamines may be
exerting a direct trophic effect on myocardial gene expression.
We intentionally did not correct hypotension with cate-
cholaminergic agents because we wanted to study the unmod-
ified phenomenon of brain death. Clinically, exogenous
inotropic stimulation has stabilized many donors, but would
not it be interesting if part of what we were doing was to sup-
ply an exogenous trophic influence while the heart and main-
tain an “optimal” pattern of gene expression?
Dr Juan C. Chachques (Paris, France). Did you study LV
function in your model? I do not see any parameters of LV
function related with the LV adrenergic expression.
Dr Yeh. We intentionally avoided invasive intrathoracic
monitoring in this model simply to minimize the cate-
cholamine release accompanying thoracotomy; therefore we
have no sophisticated functional analyses of these hearts.
Nevertheless, this type of analysis will ultimately be central
in defining exactly what is a “favorable” pattern of gene
expression.
